Cliical Trials: Companion Diagnostics & Precision Medicine

How Companion Diagnostics & Precision Medicine Supports Precision Medicine and Biomarker-Driven Trials The integration of companion diagnostics and precision medicine has transformed the landscape of clinical trials. As the pharmaceutical industry continues to lean towards targeted therapies, the implications for clinical operations, regulatory affairs, and R&D professionals are profound. In this step-by-step tutorial, we will…

Read More “How Companion Diagnostics & Precision Medicine Supports Precision Medicine and Biomarker-Driven Trials” »

Roadmap: 12–24 Month Plan to Upgrade Your Organization’s Companion Diagnostics & Precision Medicine Introduction to Companion Diagnostics and Precision Medicine The field of companion diagnostics has gained significant traction in the realm of personalized medicine. Understanding the landscape of patient enrollment in clinical trials is critical for clinical research professionals involved in pharmaceutical R&D and…

Read More “Roadmap: 12–24 Month Plan to Upgrade Your Organization’s Companion Diagnostics & Precision Medicine” »

Sustainability, ESG and Green R&D Considerations in Companion Diagnostics & Precision Medicine Introduction to Sustainability in Clinical Trials The integration of sustainability into clinical research, particularly in the realm of companion diagnostics and precision medicine, has emerged as a critical area of focus for pharmaceutical companies. As environmental, social, and governance (ESG) criteria gain traction,…

Read More “Sustainability, ESG and Green R&D Considerations in Companion Diagnostics & Precision Medicine” »

IP, Exclusivity and Deal-Making Implications of Strong Companion Diagnostics & Precision Medicine IP, Exclusivity and Deal-Making Implications of Strong Companion Diagnostics & Precision Medicine Understanding the Role of Companion Diagnostics in Clinical Trials Companion diagnostics play a pivotal role in enhancing the precision of patient selection during clinical trials, particularly in fields such as oncology…

Read More “IP, Exclusivity and Deal-Making Implications of Strong Companion Diagnostics & Precision Medicine” »

Risk Management and Stage-Gate Governance for Companion Diagnostics & Precision Medicine Introduction to Companion Diagnostics and Precision Medicine In the evolving landscape of pharmaceutical development, the integration of companion diagnostics in precision medicine has gained paramount importance. Companion diagnostics are essential tools facilitating personalized treatment approaches, enabling healthcare professionals to make informed decisions based on…

Read More “Risk Management and Stage-Gate Governance for Companion Diagnostics & Precision Medicine” »

AI, ML and Automation Use-Cases That Unlock Value in Companion Diagnostics & Precision Medicine The integration of Artificial Intelligence (AI), Machine Learning (ML), and automation within the domain of companion diagnostics and precision medicine is rapidly transforming the landscape of pharmaceutical R&D. This tutorial guides clinical research professionals through the step-by-step implementation of these advanced…

Read More “AI, ML and Automation Use-Cases That Unlock Value in Companion Diagnostics & Precision Medicine” »